Page last updated: 2024-08-23

quisqualic acid and rofecoxib

quisqualic acid has been researched along with rofecoxib in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellucci, A; Casamenti, F; Giovannini, MG; Pepeu, G; Prosperi, C; Scali, C1

Other Studies

1 other study(ies) available for quisqualic acid and rofecoxib

ArticleYear
The selective cyclooxygenase-2 inhibitor rofecoxib suppresses brain inflammation and protects cholinergic neurons from excitotoxic degeneration in vivo.
    Neuroscience, 2003, Volume: 117, Issue:4

    Topics: Alzheimer Disease; Animals; Astrocytes; Brain; Cell Death; Choline O-Acetyltransferase; Cholinergic Fibers; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Encephalitis; Gliosis; Isoenzymes; Lactones; Male; Microglia; Mitogen-Activated Protein Kinases; Nerve Degeneration; Neurons; Neuroprotective Agents; Neurotoxins; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prostaglandin-Endoperoxide Synthases; Quisqualic Acid; Rats; Rats, Wistar; Sulfones

2003